EPLAW PATENT BLOG

UPC – NanoString Technologies v. 10x Genomics and President and Fellows of Harvard College

Posted: March 11th, 2024

NanoString Technologies Inc et al. v. 10x Genomics, Inc. and President and Fellows of Harvard College, Order of the Court of Appeal of the Unified Patent Court, 11 March 2024, Case no. UPC_CoA_335/2023 Correction of ´obvious slip´ in the order of 26 February 2024 `With regard to an obvious slip in Headnote 2, paragraph 3 […]

READ MORE

NL – Novartis v. Mylan / Supreme Court

Posted: March 11th, 2024

Novartis A.G. v. Mylan B.V. and Mylan Ireland Limited, Supreme Court The Hague, The Netherlands, 8 March 2024, Case no. ECLI:NL:HR:2024:341 Appeal to the Supreme Court regarding fingolimod. Earlier, Novartis alleged Mylan infringed its Patent. In first instance PI proceedings, the preliminary relief Judge ruled that there was a serious, non negligible chance that the […]

READ MORE

UPC – NanoString v. 10x Genomics: UPC Court of Appeal’s first substantive decision overturns NanoString preliminary injunction due to doubts over validity

Posted: February 28th, 2024

NanoString Technologies, Inc, NanoString Technologies Germany GmbH & NanoString Technologies Netherlands B.V. v. 10x Genomics, Inc & President and Fellows of Harvard College – Court of Appeal – Luxembourg, 26 February 2024, Case no. UPC_CoA_335/2023 App_576355/2023, by Sarah Taylor and Julia Traumann, Pinsent Masons The Unified Patent Court (‘UPC’) Court of Appeal has overturned an […]

READ MORE

EPLAW – Young EPLAW Congress: Registration now open

Posted: February 28th, 2024

The Young EPLAW Congress is to be held on 29 April 2024 in The Hotel, Brussels. EPLAW members have received a link which they can forward to their eligible associates. An informal reception will take place on 28 April from 7 to 11pm in The Merode, which is walking distance from the venue. A limited […]

READ MORE

UPC – Plant-e Knowledge v. Arkyne Technologies / The Hague Local Division takes pragmatic approach to bifurcation

Posted: February 22nd, 2024

Plant-e Knowledge v Arkyne Technologies – The Hague Local Division takes pragmatic approach to bifurcation by Sarah Taylor, Pinsent Masons Plant-e Knowledge B.V & Plant-e B.V. v Arkyne Technologies S.L – Court of First Instance – The Hague (NL) Local Division, 15 February 2024, Case no. UPC_CFI_239/2023 A topic often discussed prior to the UPC’s […]

READ MORE

NL – Dutch Trading Office v. CNC Grondstoffen

Posted: February 20th, 2024

Dutch Trading Office B.V. v. CNC Grondstoffen B.V., District Court The Hague, The Netherlands, 23 October 2023, Case no. ECLI:NL:RBDHA:2023:15621 Method of transporting mushroom compost. No infringement: “Placing blocks on pallets in this manner does not meet the characteristics that stacked compost blocks are supported by spacer(s), providing rows and columns of stacked blocks, leaving […]

READ MORE

USA – USPTO Notice ‘Inventorship Guidance for AI-Assisted Inventions’

Posted: February 14th, 2024

On 13 February 2024 the United States Patent and Trademark Office, Department of Commerce published a notice regarding ‘Inventorship Guidance for AI-Assisted Inventions’ SUMMARY: “Pursuant to the “Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence” (October 30, 2023), the United States Patent and Trademark Office (USPTO or Office) is […]

READ MORE

​​EPO – Guidelines 2024 / consultation

Posted: February 13th, 2024

The EPO recently published the updated Guidelines 2024, which enter into force on 1 March. Users are invited to comment on them by 2 April and are encouraged to take a small survey on the annual revision process included in the consultation. The Guidelines and more information on the consultation can be found here.  

READ MORE

UPC – Dexcom v. Abbott Laboratories et al.

Posted: February 9th, 2024

Dexcom, Inc. v. Abbott Laboratories, Abbott Diabetes Care inc, Abbott France, Abbott NV/SA, Abbott B.V, Abbott S.r.l, Abbott Scandinavia Aktiebolag, Abbott GmbH, Abbott Diagnostics GmbH, Abbott Logistics B.V, Court of First Instance – Paris (FR) Local Division, 30 January 2024, Case no. UPC_CFI_230/2023 Review by the panel pursuant to R. 333 RoP. Request to harmonise […]

READ MORE

NL – Janssen Biotech v. Samsung Bioepis / Manufacturing Waiver

Posted: February 2nd, 2024

Janssen Biotech Inc. v. Samsung Bioepis NL B.V., PI Proceedings, District Court The Hague, The Netherlands, 23 January 2024, Case no. ECLI:NL:RBDHA:2024:701 PI proceedings, SPC. Explanation of Manufacturing Waiver Regulation (EU) No. 2019/933. Manufacturing of biosimilar for export to third countries. Samsung Bioepis successfully invokes the manufacturing waiver. Reference number of marketing authorisation in export […]

READ MORE